Shopping Cart
- Remove All
- Your shopping cart is currently empty
PB2, a tris(2-carboxyethyl)phosphine (TCEP) analogue, enhances the survival of retinal ganglion cells (RGCs) following axotomy in vitro. Even at nanomolar and picomolar concentrations, PB2 demonstrates pronounced efficacy in promoting RGC survival. Notably, PB2 exhibits superior permeability compared to TCEP. Serving as a potent reducing agent, PB2 provides robust neuroprotection for RGCs[1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $95 | 5 days | |
5 mg | $178 | 7-10 days | |
10 mg | $347 | 7-10 days | |
1 mL x 10 mM (in DMSO) | $178 | 7-10 days |
Description | PB2, a tris(2-carboxyethyl)phosphine (TCEP) analogue, enhances the survival of retinal ganglion cells (RGCs) following axotomy in vitro. Even at nanomolar and picomolar concentrations, PB2 demonstrates pronounced efficacy in promoting RGC survival. Notably, PB2 exhibits superior permeability compared to TCEP. Serving as a potent reducing agent, PB2 provides robust neuroprotection for RGCs[1]. |
In vitro | PB2 (0.001~100000 nM; 72 hours; RGCs) increases RGC viability[1]. PB2's modifications neutralize compound polarity, and its methyl esters are likely cleaved by cytosolic esterases, producing a polar intracellular intermediate that is unlikely to cross cell membranes[1]. |
Molecular Weight | 286.12 |
Formula | C16H20BO2P |
Cas No. | 914940-24-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (349.52 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.